Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

142P - Relation between Interleukin -4 (590C/T) gene polymorphism and hepatocellular carcinoma risk in HBV and HCV patients

Date

23 Nov 2019

Session

Poster display session

Topics

Cytotoxic Therapy

Tumour Site

Hepatobiliary Cancers

Presenters

Suzy Gohar

Citation

Annals of Oncology (2019) 30 (suppl_9): ix42-ix67. 10.1093/annonc/mdz422

Authors

S.F. Gohar1, B. Montaser2, N. Elabd3, M. Elhamoly3, A. Saleh4, E. Salem5, G. Abo-Zeid6, M. Rizk7

Author affiliations

  • 1 Oncology, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 2 Clinical Pathology, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 3 Tropical Medicine, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 4 Medical Biochemistry, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 5 Medical Microbiology And Immunology, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 6 Clinical Oncology, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG
  • 7 Internal Medicine, Faculty of Medicine - Menoufia University, 32511 - Shebin El Kom/EG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 142P

Background

Interleukin-4 (IL-4) is an important modulator in the immune response of macrophages, B and T cells to stand in front of infections and malignancy. This study aimed to assess the association between IL-4 gene 590CT polymorphism and risk of hepatocellular carcinoma (HCC) on top of viral hepatitis.

Methods

This study was conducted on 220 patients and 60 apparently healthy individuals. One hundred and twenty patients with HCV infection (group 1) classified as sixty patients with liver cirrhosis and sixty with HCC, one hundred patients with HBV infection (group 2) classified as fifty with liver cirrhosis and fifty with HCC. Virus status of the patients was confirmed by measuring HBsAg, HCV antibodies and real time PCR. Liver cirrhosis was assessed by laboratory investigations, abdomino-pelvic ultrasound and CHILD score. Patients with HCC were diagnosed by triphasic CT, alphafeto-protein level (AFP) and biopsy. The studied groups were genotyped for IL-4 590C/T gene polymorphisms by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

Results

IL-4 590C/T gene analysis detected significant variation between studied groups, regarding genotype and allele frequencies (p = 0.025 and p = 0.002 respectively). There were higher frequencies of CC genotype and C allele in HCC and cirrhotic hepatitis C patients than controls. C allele had higher prevalence in HCC than cirrhosis in HBV patients. CT+CC genotype carriers had an elevated HCC risk odd ratio (OR): 4.6 [95% CI: 1.5 –14] and OR 3.6 [95% CI: 1.1 –11.6], in HCV and HBV patients in contrast to controls. C allele was associated with increased cirrhotic and HCC risk in HCV infected patients with OR = 4 [95% CI: 1.8 – 8.8] and OR = 2.3 [95% CI: 1.1 – 5.2] versus control group. In HBV patients C allele showed higher HCC risk with OR = 4.2 [95% CI: 1.8 – 9.5] when compared to controls.

Conclusions

IL-4 590C/T gene polymorphism may have a role in occurrence of HCC on top of liver cirrhosis.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.